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The crystal structure of ADP-L-glycero-D-mannoheptose
6-epimerase: catalysis with a twist
AM Deacon1, YS Ni2, WG Coleman Jr2* and SE Ealick1*
Background: ADP-L-glycero-D-mannoheptose 6-epimerase (AGME) is required
for lipopolysaccharide (LPS) biosynthesis in most genera of pathogenic and
non-pathogenic Gram-negative bacteria. It catalyzes the interconversion of
ADP-D-glycero-D-mannoheptose and ADP-L-glycero-D-mannoheptose, a
precursor of the seven-carbon sugar L-glycero-D-mannoheptose (heptose).
Heptose is an obligatory component of the LPS core domain; its absence
results in a truncated LPS structure resulting in susceptibility to hydrophobic
antibiotics. Heptose is not found in mammalian cells, thus its biosynthetic
pathway in bacteria presents a unique target for the design of novel
antimicrobial agents.
Results: The structure of AGME, in complex with NADP and the catalytic
inhibitor ADP-glucose, has been determined at 2.0 Å resolution by
multiwavelength anomalous diffraction (MAD) phasing methods. AGME is a
homopentameric enzyme, which crystallizes with two pentamers in the
asymmetric unit. The location of 70 crystallographically independent selenium
sites was a key step in the structure determination process. Each monomer
comprises two domains: a large N-terminal domain, consisting of a modified
seven-stranded Rossmann fold that is associated with NADP binding; and a
smaller α/β C-terminal domain involved in substrate binding.
Conclusions: The first structure of an LPS core biosynthetic enzyme leads to
an understanding of the mechanism of the conversion between ADP-D-glycero-
D-mannoheptose and ADP-L-glycero-D-mannoheptose. On the basis of its high
structural similarity to UDP-galactose epimerase and the three-dimensional
positions of the conserved residues Ser116, Tyr140 and Lys144, AGME was
classified as a member of the short-chain dehydrogenase/reductase (SDR)
superfamily. This study should prove useful in the design of mechanistic and
structure-based inhibitors of the AGME catalyzed reaction.
Introduction
Gram-negative bacteria possess two membranes that sep-
arate the cytoplasmic compartment from the extracellular
environment: the cytoplasmic membrane and the outer
membrane. The properties of the cytoplasmic membrane
are consistent with those of a typical phospholipid
bilayer. The outer membrane is also a bilayered structure:
the inner most leaflet is composed primarily of phospho-
lipids, whereas its outer one contains a unique lipid
known as lipopolysaccharide (LPS). 
The LPS of most Gram-negative bacteria consists of lipid
A, core and O-antigen domains. The core oligosaccharide
has an outer portion composed of hexoses and N-acetyl-
glucosamine and an inner portion composed of the seven-
carbon sugar L-glycero-D-mannoheptose (or heptose) and
2-keto-3-deoxyoctulosonic acid. Heptose is a highly con-
served component of the LPS core among several genera
of enteric and nonenteric bacteria [1]. 
LPS has an important role in maintaining the structural
integrity of the outer membrane by interacting with
other components and providing a physical barrier
against the entry of deleterious compounds and some
bacteriophages [2]. Escherichia coli K-12 LPS heptose-
less mutants (resulting from a single-site mutation,
designated rfaD70) display a dramatic reduction in
porin proteins and are unable to grow in media contain-
ing detergents, bile salts or hydrophobic antibiotics
[2,3]. The increased permeability of hydrophobic
agents across the outer membrane of heptoseless or
other rfaD mutants is directly attributed to the loss
of the barrier function. Furthermore, the ability of hep-
toseless or core-defective LPS mutants to survive
in body sites of infected hosts is compromised [4].
The LPS biosynthetic pathway is an attractive thera-
peutic target, as mutants that produce core-defective
LPS are less pathogenic and more susceptible to known 
antibiotics [2–4].
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ADP-L-glycero-D-mannoheptose 6-epimerase (AGME)
catalyzes the interconversion between ADP-D-glycero-D-
mannoheptose and ADP-L-glycero-D-mannoheptose, the
last step (Figure 1) in the biosynthesis of the precursor of
L-glycero-D-mannoheptose [5–8]. In 1983, AGME activity
was first demonstrated in extracts of E. coli K-12 [7]. In
1990, the gene encoding AGME (rfaD) was cloned; the
gene product was partially purified and the N terminus of
the primary structure of the protein was shown to contain
the ADP-binding βαβ fold fingerprint sequence, Gly-Gly-
X-Gly-X-X-Gly [8,9]. AGME was purified to homogeneity
in 1994 and several physicochemical properties of the
enzyme were investigated [10]. The enzyme was shown to
be an NADP-dependent epimerase, but also has dimin-
ished activity with NAD. The cofactor is tightly bound to
AGME and its removal resulted in a loss of enzyme activ-
ity and secondary structure. Preliminary crystallization and
X-ray studies of AGME were recently reported [11].
The occurrence of the epimerase in several genera of
Gram-negative bacteria and its absence in mammalian
cells makes this protein a suitable target for new antimicro-
bial strategies. The X-ray structure determination of
AGME was undertaken to better understand the mecha-
nism of catalysis, inhibition and inactivation, and to permit
the design of potent and selective mechanism-based
inhibitors. The enzyme is a homopentamer. Each
monomer is comprised of two domains: a large N-terminal
domain consisting of a modified seven-stranded Rossmann
fold that is associated with NADP binding; and a smaller
α/β C-terminal domain involved in substrate binding. The
C-terminal domain appears to position the substrate with
respect to the nicotinamide. Subtle variations in the con-
formation of this domain allow the substrate sugar to twist,
thereby allowing the catalytic epimerization reaction to
proceed. On the basis of its high structural similarity with
UDP-galactose epimerase and the three-dimensional posi-
tions of the conserved residues Ser116, Tyr140 and
Lys144, AGME is classified as a member of the short-
chain dehydrogenase/reductase (SDR) superfamily. 
Results and discussion
Structure determination by MAD phasing
AGME exhibits low sequence identity with other enzymes
and early attempts to determine the structure by molecular
replacement were unsuccessful. The presence of seven
methionine residues in each 310 amino acid monomer,
however, offered us the possibility of using selenomethio-
nine-based multiwavelength anomalous diffraction (MAD)
for phase determination. Preliminary X-ray characteriza-
tion of AGME [11] showed that it crystallized in space
group P21. The cell dimensions (a = 99.5 Å, b = 109.8 Å,
c = 181.5 Å, β = 91.0°) implied that several monomers were
present in the asymmetric unit. Early biochemical analysis
(i.e., sodium dodecyl sulfate polyacrylamide gel electro-
phoresis, gel filtration and sedimentation equilibrium
studies) of AGME suggested a homohexameric structure
[10] and we initially assumed either one or two hexamers
were located in the asymmetric unit [11]. Self-rotation
searches performed against the native X-ray diffraction
data using the program GLRF [12], however, revealed
fivefold noncrystallographic symmetry (NCS), indicating
that the enzyme was in fact pentameric. In addition, a rea-
sonable Matthews coefficient [13] of 2.7 Å3/Da and a
solvent content of 53%, both corresponded to there being
two such pentamers in the asymmetric unit. Therefore, 70
crystallographically independent selenium sites had to be
located as part of the MAD phasing process.
The selenium substructure was determined with the
SnBv2.0 package [14]. The peak wavelength anomalous dif-
ferences were processed with the DREAR suite [15] to gen-
erate difference normalized structure factors (diffE values)
[16]. The largest 1400 diffE values were used in SnBv2.0 to
generate 14,000 triplet invariants. All trials were conducted
on a 500 MHz Digital/Compaq Alpha workstation, taking
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Figure 1
The biosynthetic pathway for ADP-L-glycero-D-
mannoheptose. This pathway was first
proposed by Eidel and Osborn [5] and has
been substantiated and further elaborated by
results from several laboratories [2,5,7,8]. Its
presentation here using chemical formulae
was adopted from a review article by CRH
Raetz [6]. (Reprinted with permission from the
Annual Review of Biochemistry,
Volume 12 © 1990 by Annual Reviews
www.AnnualReviews.org.)
20 min per random trial. Each trial was processed for 140
cycles of dual-space refinement. After 236 trials had been
processed, one trial was identified that had a significantly
lower minimal function value [17] (Rmin = 0.43) compared
to the other 235 trials (Rmin = 0.55–0.60). This indicated
that the 70 selenium atom substructure had been unam-
biguously determined. All of these initial trials were
carried out using an electron-density grid size of 0.9 Å.
Later it was found that similar success rates could be
achieved using a substantially coarser grid of 2.0 Å. The
use of a coarser grid realized an almost eightfold increase
in the speed performance of SnB.
Once the selenium atoms had been located their positions
were confirmed in several ways. Firstly, in the absence of a
second independent SnB solution, five of the top peaks
from the initial solution were fed back into the SnB program
as a new starting trial. The minimal function quickly con-
verged again to 0.43. The resulting substructure consis-
tently matched the original solution, no matter which five of
the top peaks were recycled in this way. Secondly, the five-
fold axes for the two pentamers were located from the sele-
nium positions; the axes were parallel to the crystallographic
21 axis and matched the previous results from self-rotation
searches. Finally, after processing more trials, the peak lists
from two completely independent SnB solutions were com-
pared. In total, 65 matching sites were found between these
two solutions. These sites were then fed into MLphare [18]
for phasing, followed by DM [19] for density modification,
according to standard protocols. The resulting electron-
density maps were of very high quality even before any
NCS averaging had been carried out (Figure 2). 
The 70 selenium atom substructure of AGME is the
largest substructure that has been used in a de novo MAD
structure determination [20]. It provided a challenging
system to test the robustness of current phasing strategies
for selenomethionine-based MAD structure determina-
tion and should encourage the use of selenomethionine as
the anomalous scatterer to solve even larger structures.
Quality of the model
The final model consisted of ten monomers (two pen-
tamers) of AGME. Four of the monomers were essentially
complete, except for three disordered amino acid residues
at the C terminus (residues 308–310). Three of the other
monomers were also missing residues 265–271, one
monomer was missing residues 262–271, one monomer
was missing residues 195–207 and 251–271 and the final
monomer was missing residues 194–206 and 249–271. The
final model also included 996 bound water molecules, ten
molecules of NADP and ten molecules of ADP-glucose
inhibitor. However, the electron density for the glucose
moiety was weak and difficult to interpret in seven of the
monomers. In these cases the inhibitor was truncated to
an ADP molecule. The refinement converged to a final R
factor of 21.2% and a free R factor of 26.2%. The final
model exhibited good stereochemical geometry. A
Ramachandran plot calculated with PROCHECK [21]
showed that 89.3% of the residues were located in the
most favored regions and the other 10.7% were in addi-
tionally allowed regions.
Overall structure
The AGME monomer measures 35 Å × 35 Å × 65 Å.
Architecturally it consists of two domains: a predominantly
N-terminal domain including amino acid residues 1–167,
214–236 and 280–292; and a smaller C-terminal domain
formed from amino acid residues 168–213, 237–279 and
293–310 (Figure 3a). The N-terminal domain consists of a
modified Rossmann fold [22], with a central seven-
stranded parallel β sheet, flanked on either side by a total
of seven α helices. This domain is associated with the
tight binding of the enzymatic cofactor NADP. The C-ter-
minal domain is a globular cluster of two small parallel 
β sheets and three α helices (Figure 3b). This domain pro-
vides the residues that define the specificity for the sub-
strate, which binds in a cleft between the two domains. 
The topology of AGME clearly shows that it is a member
of the SDR family. The overall structure is very similar to
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Figure 2
Electron-density plots of the NADP molecule.
(a) Experimental phases without averaging at
3.0 Å resolution. (b) Experimental phases with
tenfold averaging at 3.0 Å resolution. (c) Final
refined phases at 2.0 Å resolution.
UDP-galactose 4-epimerase (UGE, Protein Data Bank
[PDB] codes 1NAH and 1NAI; Figure 3c) [23], with a root
mean square (rms) deviation of 1.88 Å for 238 Cα atoms,
and dTDP-D-glucose 4,6 dehydratase (DGD, PDB code
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Figure 3
Structure of the AGME monomer. (a) Ribbon
diagram of AGME showing its overall fold. The
N-terminal domain consist of a seven-stranded
Rossmann fold associated with NADP binding
and the C-terminal domain consists of a small
α/β domain involved in substrate binding. The
numbered β strands are represented as green
arrows and the α helices as purple spirals;
loops are represented as orange pipes. NADP
and ADP-glucose are shown in ball-and-stick
representation. (b) Stereoview Cα trace of
AGME. The N and C termini and every
twentieth residue are labeled. The polypeptide
chain is color-coded from the N terminus
(green) to the C terminus (purple). The red
region is disordered in some of the ten
monomers in the asymmetric unit.
(c) Superimposition of the Cα traces of AGME
(green) and UGE (red), showing bound NAD
and NADP. NADP and ADP-glucose are
shown in cyan; NAD and UDP-phenol are in
orange. The illustration was prepared using the
program MOLSCRIPT [33].
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Structure
1BXK), with an rms deviation of 1.85 Å for 237 Cα atoms.
Similarity is also seen with the structure of GDP-4-keto-6-
deoxy-D-mannose epimerase/reductase (GMER, PDB
code 1BWS) [24,25], which has a modified Rossmann fold
with a six-stranded parallel β sheet (rms deviation of
2.14 Å for 226 Cα atoms). These proteins typically show
about 20–30% sequence conservation. 
Quaternary structure and intersubunit contacts
AGME is a homopentamer with the individual subunits
related by a local fivefold symmetry axis (Figure 4a).
NAD(P)-dependent enzymes are often either dimers or
tetramers. In particular, many members of the SDR family
are dimers [25] and share a common dimer interface motif,
in which the long α4 and α5 helices from the N-terminal
domain of each subunit pack together to form a four-helix
bundle [24]. This interface results in the C-terminal sub-
strate-binding domains being located on opposite sides of
the dimer. In the AGME pentamer the subunit interface is
also formed solely from the N-terminal domains. However,
the contributing residues are from helix α2 and strand β3 of
one subunit and helices α4 and α5 of the adjacent subunit.
This interface buries 1750 Å2 surface area per monomer,
compared with a total monomer surface area of 11,250 Å2.
The local fivefold symmetry results in the C-terminal
domains of the individual subunits being arranged on the
same face of the pentamer, with the substrate-binding cleft
facing towards the interior of the pentamer (Figure 4b).
Nevertheless, there are no interactions between the C-ter-
minal domains of the individual subunits. The AGME
pentamer measures 70 Å on each side, with a channel
down the center. The channel measures 50 Å across
between residues from the C-terminal domain and narrows
to 30 Å across at the base, between residues from the
N-terminal domain, where the subunits are tightly packed
(Figure 4b). The disordered residues that were omitted
from the final model (described above) were all located in
the C-terminal domain, mainly in β strands β7 and β11 and
their connecting loops. This region is involved in rather
weak crystal-packing contacts with the same region from
an adjacent pentamer. The precise contacts vary from
monomer to monomer. The most well ordered monomers
are involved in more intimate crystal contacts with a few
direct hydrogen bonds, whereas the more disordered
monomers lack any significant crystal contacts in the
C-terminal domain. These weak interpentamer crystal
contacts contributed to the significant anisotropic diffrac-
tion that was observed for crystals of AGME.
An electrostatic surface calculated for AGME is charac-
terized by a large negatively charged area on the base of
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Figure 4
Structure of the AGME pentamer. (a) Ribbon
representation of the  AGME pentamer with
space-filling representations of NADP and
ADP-glucose. (b) Corey, Pauling and Koltun
(CPK) space-filling representation of the
AGME pentamer (N-terminal domain in green;
C-terminal domain in blue). (c,d) van der
Waals surface representation of AGME. The
surface is colored according to electrostatic
potential: blue for positive and red for
negative. The bottom surface (d) is very
negative. The top view (c) is less interesting
electrostatically, but does show the overall
shape with the small substrate-binding
domain arranged on top of the larger NADP-
binding domain. The figure was prepared
using the program GRASP [34].
the pentamer (residues Asp26, Glu64, Glu65, Asp68,
Glu70, Glu106, Glu108, Glu132, Glu157 and Glu226) and
also around the interior surface at the bottom of the pen-
tamer (residues Asp52, Glu54, Asp55, Asp85, Asp91 and
Glu99; Figure 4c).
NADP-binding site
The NADP-binding site is located at the topological switch
point of the N-terminal domain modified Rossmann fold.
The binding site is characterized by the fingerprint
sequence Gly-Gly-X-Gly-X-X-Gly, which forms a tight
loop between β1 and α1 (residues 6–12). The NADP is
tightly bound in an extended conformation with an average
distance of 12.90 Å (range 12.71–13.12 Å over the ten
monomers) between the adenine C6 and the nicotinamide
C2 position (Figure 5a). This is shorter than the distances
observed in other similar structures (13.91 Å for UGE,
14.39 Å for DGD and 15.47 Å for GMER). This more
closed conformation allows AGME to accommodate NADP
rather than NAD, with extra specificity for the phosphate
being provided by Lys53 and Asn32 and two tightly bound
water molecules. In addition, the loop between Asp31 and
Tyr50, which closes over the cofactor like a lid, is in a more
open conformation than compared with UGE (which binds
NAD). This region provides extra specificity for NADP,
while maintaining the same tight binding of the cofactor as
UGE. This lid region is missing in GMER. AGME exhibits
a loss of secondary structure but the active enzyme can be
reconstituted on addition of fresh cofactor. GMER, on the
other hand, shows little change in structure between the
NADP-bound and free forms [24,25]. The importance of
the fingerprint sequence associated with cofactor binding is
demonstrated by a single-site mutation in this region [2,3].
The mutation, designated rfaD70, results in a Gly6→Ser
substitution. The mutation of glycine to serine alters the
size and flexibility of the NADP-binding motif, resulting in
an inactive enzyme. Consequently, the rfaD70 mutation
results in heptoseless LPS structures.
The adenine base is firmly locked in position through
hydrophobic stacking interactions between the entire
length of the Lys53 sidechain on one side and the main-
chains of Gly76 and Ala77 on the other (Figure 5a). Further-
more, hydrogen bonds coordinating the carbonyl oxygen
and the OD1 of Asn92 with the N6 and N7 of the adenine
base cause a distortion in the longest α helix (α4), which
results in four amino acid residues in a single turn of the
helix. The carbonyl oxygen of Asn92 does not participate in
the regular α-helical hydrogen-bonding pattern. Conse-
quently, the carbonyl oxygens of Met90 and Asp91 are
hydrogen bonded to the mainchain nitrogen atoms of amino
acids five residues ahead in the chain. A similarly distorted
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Figure 5
The cofactor- and substrate-binding sites of
AGME. (a) The NADP-binding site. (b) The
ADP-glucose-binding site. Potential hydrogen
bonds are indicated by dashed lines with
distances given in Å, the numbers in brackets
indicate the standard deviation of the
equivalent distances for all ten AGME
molecules. Shaded boxes indicate
hydrophobic contacts. Atoms are shown in
standard colors: carbon, black; nitrogen, blue;
oxygen, red; phosphorus, magenta.
(c) Stereoview of the active site, two AGME
molecules are superimposed (red and green).
The glucose moiety of the substrate (ADP-
glucose) adopts two different conformations.
For clarity only selected residues are shown.
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feature is also present in the structure of UGE, however, in
GMER the helix appears to be normal and the coordination
of the adenine at this point is somewhat different. 
Finally, an oxidized cysteine residue (Cys78) is involved
in coordinating the adenosine ribose 2′-phosphate. The
cysteine appears to be a fully occupied sulfenic acid in all
ten monomers. In some of the monomers it coordinates
directly, whereas in others the coordination is via a bridg-
ing water molecule.
The average atomic temperature factor of the NADP mol-
ecules is 28.2 Å2. The temperature factor at the nicotinamide
end, however, is consistently higher (average of 33.2 Å2) than
at the more tightly bound adenine end (average of 24.2 Å2).
There is also more variation in the average temperature
factors of the nicotinamide moiety of the ten monomers.
This suggests that there is more flexibility at this end of the
cofactor, and as a result the electron density is less well
defined. The density was still of sufficient quality, however,
to allow the unambiguous assignment of the orientation of
the nicotinamide. The nicotinamide moiety adopts the syn
conformation with respect to the ribose, similar to the find-
ings for UGE in complex with UDP-sugars [26]. This is con-
sistent with a nicotinamide B side specific pro-S hydride
transfer during catalysis.
Substrate-binding site
The ADP-glucose-binding site is characterized by strong
hydrophobic interactions at the adenine base. In particular,
stacking interactions sandwich the base between Phe201
and Phe243 (Figure 5b). In addition, the pyrophosphate is
pinned in place through hydrogen bonds to Arg273. There
appear to be far fewer interactions between the protein
and the glucose moiety. As a result, the electron density
for the glucose moiety showed more disorder and was diffi-
cult to interpret. Although significant electron density was
present in all ten monomers, it could only be satisfactorily
interpreted to assign the orientation of the glucose in three
of these. The average temperature factor of the ADP-
glucose (55.4 Å2) is higher than that of the NADP cofactor
(28.2 Å2) and shows significantly more variation from
monomer to monomer. Furthermore, for the three mol-
ecules that have the sugar included in the refined model
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Figure 6
Comparison of AGME monomers.
(a) Stereoview superposition of Cα traces of
ten monomers of AGME. The C-terminal
domain adopts one conformation in five of the
molecules (red) and an alternative
conformation in the other five molecules
(green). (b,c) CPK space-filling model of two
monomers of AGME comparing the different
binding of the glucose moiety of ADP-
glucose. ADP-glucose (yellow) is more
exposed in (c); NADP (red) is uniformly bound
in both monomers. The substrate domain
(domain B) is in blue and the NADP-binding
domain (domain A) is in green. 
the ADP-glucose analog has significantly higher tempera-
ture factors at the glucose sugar position (71.6 Å2) than
compared with the adenine base (45.2 Å2) .
The glucose moiety appears in two significantly different
orientations in these three molecules, represented primarily
by a rotation of approximately 125° in the torsion angle
formed from the pyrophosphate linking oxygen, the
β-phosphate, the glycosyl oxygen and the glucose C1 posi-
tion. This twist effectively rotates the β-phosphate O3 onto
the O1 position. There is also an additional smaller rotation
around the torsion angle formed from the β-phosphate, the
glycosyl oxygen, the glucose C1 and the glucose C2 posi-
tions. Even though the sugar is not well enough defined in
the other seven monomers for it to be included in the
refined model, there is nevertheless significant electron
density at either the O1 or the O3 position in each mol-
ecule, which gives some indication of the more likely
glucose orientation. In both orientations the C6 of the
glucose is located near to the C4 of the NADP nicotinamide
moiety (4.13 Å and 3.96 Å for the molecules in one orienta-
tion and 3.27 Å for the molecule in the other orientation).
Domain conformation and catalytic mechanism
The catalytic mechanism of AGME appears to be consis-
tent with the one proposed for UGE [26]. The key active-
site residues identified in the structural and biochemical
analysis of UGE are generally conserved within members
of the SDR family, and are also conserved in AGME
(Figure 5c). In particular, Ser116, Tyr140 and Lys144 of
AGME are all located in structurally similar positions
when compared with the equivalent residues in UGE. All
these residues are in close proximity to the ADP-glucose
and Ser116 and Tyr140 are 4.5 Å and 4.8 Å from the C4
position of the nicotinamide group, respectively. 
In analogy to UGE, where it was found that UDP-galac-
tose and UDP-glucose bound to an inactive mutant of the
enzyme in different orientations [26], we observe differ-
ences in the orientation of the inhibitor ADP-glucose in
the ten monomers of the asymmetric unit. In the case of
AGME, however, the active enzyme is used but with a
substrate analog that is slightly smaller (i.e., one carbon
less). Furthermore, in AGME the orientation of the
glucose moiety appears to be correlated with the relative
conformation of the C-terminal domain with respect to
N-terminal domain. The ten monomers of AGME super-
impose with an rms deviation in the range 0.089–0.256 Å if
only the first 160 Cα atoms (i.e., all residues from the
N-terminal domain) are used in the calculation. However,
if all the available Cα atoms are used then the rms devia-
tion increases significantly (0.236–0.965 Å).
There appear to be two distinct conformations for the
C-terminal domain (Figure 6a). These conformations
seem to be dictated by variations in the crystal-packing
freedom of the individual monomers. Five of the
monomers are clearly seen to adopt a more closed confor-
mation, whereas the other five monomers adopt a slightly
more open conformation. The monomers where the ADP-
glucose is in a similar orientation belong to one of these
species, whereas the other monomer, with the ADP-
glucose in an alternative orientation, belongs to the other
species. Even in the cases where the sugar is missing from
the final refined model there is a clear correlation between
the relative domain conformation and the location of the
uninterpreted sugar electron density (i.e., either close to
the O1 or the O3 position). The ADP-glucose is clearly
more solvent exposed in the second, more open conforma-
tion (Figure 6b). A potential cycling between open and
closed conformations may also facilitate substrate binding
and product release.
Despite the observed differences in conformation and
ADP-glucose binding of the individual monomers, there
does not appear to be any cooperativity between them with
respect to substrate binding and catalysis. As was discussed
earlier, there are no interactions between the substrate-
binding domains of the individual subunits (Figure 3b), an
observation that is consistent with other members of the
SDR family where the substrate-binding sites are on oppo-
site sides of the dimer. It appears that the C-terminal
domain simply acts to position the substrate with respect to
the nicotinamide, and subtle variations in the conformation
of this domain allow the substrate sugar to twist thereby
allowing the catalytic epimerization reaction to proceed.
Biological implications
Bacterial resistance to antibiotic therapies represents a
major challenge to clinicians worldwide. Both intrinsic
and acquired factors can cause antimicrobial resistance.
The intrinsic resistance of Gram-negative bacteria to
oligopeptides and hydrophobic molecules such as antibi-
otics is attributed to the low permeability of the outer
membrane. Lipopolysaccharide (LPS), lipid, and protein
are the components of the outer membrane. Characteris-
tics of LPS determine the barrier function of the outer
membrane; severe truncation of the LPS structure
results in reduced growth rate, increased temperature
sensitivity and hypersensitivity to detergents and
hydrophobic antibiotics. ADP-L-glycero-D-mannohep-
tose 6-epimerase (AGME) catalyzes the interconversion
of ADP-D-glycero-D-mannoheptose and ADP-L-glycero-
D-mannoheptose. This epimerization reaction is the last
of four enzymatic steps required in the biosynthesis of
the precursor of the seven-carbon sugar L-glycero-D-
mannoheptose (heptose). Heptose is an obligatory com-
ponent of the LPS core domain. AGME mutants are not
capable of LPS inner-core biosynthesis resulting in the
loss of the intrinsic resistance of Gram-negative bacteria.
Thus, AGME represents a suitable target for the design
of a novel class of antimicrobial agents.
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In this study, we determined the crystal structure of
Escherichia coli K-12 AGME by multiwavelength anom-
alous diffraction (MAD) phasing of the selenomethionyl
form of the enzyme. This is the first reported three-
dimensional structure for any LPS inner-core biosyn-
thetic enzyme. A model comprising ten monomers of the
enzyme, each with tightly bound NADP and less tightly
bound ADP-glucose, has been refined to 2.0 Å resolu-
tion. The model provides the first structural information
for elucidating the mechanism of catalysis, inhibition and
inactivation. The results of this study should be useful
for the design of potent and selective mechanism-based
inhibitors of AGME. 
Materials and methods
Protein purification 
AGME was overproduced in E. coli strain BL21 (DE3) pLysS
(Novagen) transformed with the plasmid-borne E. coli K-12 rfaD gene
(i.e., pCG6) [5]. Cells were grown in luria broth medium [5] aerobically
at 37°C to OD600 ≈ 0.8, at which time isopropyl-β-D-thiogalactoside
(IPTG) was added to 0.4 mM. AGME was then purified to apparent
homogeneity using purification protocols previously described [10,11]. 
Incorporation of selenomethionine and crystallization
To prepare selenomethionyl epimerase protein, plasmid pCG6 containing
the epimerase gene [8] was transformed into the methionine auxotrophic
E. coli strain BL41 (DE3) pLysS (kindly supplied by JR Horton). The trans-
formed bacteria were grown in 10 l of LeMaster medium [27] supple-
mented with 0.05 g of selenomethionine (SeMet). Cells were harvested
3 h after induction with 0.4 mM IPTG and the SeMet protein was purified
as described above, except that all buffers contained 3 mM β-mercap-
toethanol and were purged continuously with helium. The level of SeMet
substitution (∼ 100%) in the purified AGME was estimated by amino acid
composition analysis. Native AGME crystals were grown from 2.0 M
ammonium sulfate and 2% PEG400 at pH 7.5 [11]. They formed in space
group P21, with cell dimensions a = 99.5 Å, b = 109.8 Å, c = 181.5 Å,β= 91.0°. Crystals of the SeMet enzyme were grown under similar condi-
tions to the native protein, although the best crystals were obtained at a
slightly lower pH (7.2–7.3). The crystals were smaller, typically
0.15 × 0.1 × 0.05 mm and more sensitive to manipulation and changes in
temperature. These crystals belonged to the same space group, with cell
dimensions a = 99.2 Å, b = 110.9 Å, c = 180.9 Å, β= 91.0°.
Data collection and reduction
MAD data were collected using an ADSC Quantum 4 CCD detector,
at three wavelengths around the Se K-edge on station F2 at the Cornell
High Energy Synchrotron Source (CHESS). Data were collected
including an inverse beam sweep for the f′′ maximum and the f′
minimum wavelengths, to guarantee the collection of all the anomalous
pairs. A remote wavelength was collected below the Se K-edge, where
the anomalous signal is absent. Cryoprotection of AGME crystals was
achieved by gradually equilibrating them against solutions of mother
liquor mixed with increasing concentrations of glycerol. At an optimal
concentration of 25% glycerol the crystals were frozen at 100K. The
crystals diffracted anisotropically. The diffraction extended to approxi-
mately 2.25 Å resolution along the b axis, whereas only weak diffraction
was observed beyond 3.0 Å resolution along the c and a axes. Native
crystals also diffracted anisotropically. Data were collected from a
single crystal at 100K to 2.0 Å resolution on station F1 at CHESS. All
data were processed with Mosflm [28] and scaled with Scala [29].
Structure determination
The positions of the selenium atoms were determined using the program
SnB v2.0 [14]. The anomalous differences at the peak wavelength were
converted into normalized diffE magnitudes with the DREAR program
suite [15]. In all, 65 of the 70 independent selenium positions were
located. The noncrystallographic symmetry fivefold axes (parallel to the
crystallographic 21 axis) of the AGME pentamers were located from the
selenium positions and were confirmed with locked self-rotation searches
with the program GLRF [10]. Heavy-atom refinement and phase calcula-
tions were carried out at 3.0 Å resolution using MLphare [18], followed
by solvent flattening with DM [19]. Clearly interpretable electron-density
maps were obtained without using any form of NCS averaging. Subse-
quently a mask was generated from the experimental bones with MAMA
[30] and NCS matrices were calculated from the selenium positions in
each monomer. These matrices were then improved with the program
IMP [31]. Full NCS averaging was performed with DM. The initial correla-
tion between the monomers was about 0.45 in DM.
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Table 1
Summary of X-ray diffraction data.
Se MAD* Monochromatic†
Data type Inflection‡ Peak‡ Remote‡ Native
Wavelength (Å) 0.9793 0.9791 0.99 0.919
Resolution (Å) 3.0 3.0 3.0 2.0
No. observations 391,088 391,325 196,899 573,756
No. unique reflections 72,470 72,504 71,662 242,238
Completeness (%)
overall 92.2 92.3 91.4 93.3
last shell§ 92.2 93.1 90.9 78.6
Rsym (%)#
overall 4.8 4.8 4.3 6.6
last shell§ 8.6 7.2 7.3 21.8
Average I/σ I
overall 31.1 31.5 25.2 11.7
last shell§ 13.4 15.5 12.2 3.0
*Data collected at the Cornell High Energy Synchrotron Source
(CHESS) beamline F2 using an ADSC Q4 detector. †Data collected at
CHESS beamline F1 using an ADSC Q4 detector. ‡The inflection point
and peak wavelengths were collected in inverse beam mode, whereas
the remote wavelength was collected at the low-energy side of the Se
edge where there is little anomalous signal and as a result no inverse
beam data were collected. §Last resolution shell for CHESS F2 MAD
data, 3.16–3.00 Å; last resolution shell for CHESS F1 native data,
2.11–2.00 Å. #Rsym = ΣΣi|Ii–<I>|/Σ<I>, where <I> is the mean
intensity of the N reflections.
Table 2
Phasing statistics, refinement statistics and model quality.
Phasing
FOM before solvent flattening 0.473
FOM after solvent flattening (no averaging) 0.804
FOM after solvent flattening (with averaging) 0.851
Refinement
Resolution (Å) 25.0–2.0
Number of atoms (average B value (Å2))
protein (mainchain) 11,898 (29.1)
protein (sidechain) 11,716 (30.5)
water 995 (33.7)
ligand 783 (38.8)
R factor (%) 21.2
Rfree (%) 26.2
Rms deviation from ideal geometry
bonds (Å) 0.012
angles (°) 1.386
FOM, figure of merit
Model building and refinement
An initial model of a single subunit, amounting to 88% of the amino
acid sequence, was built with the program O [31]. The known location
of the selenium sites (including two consecutive amino acid residues)
allowed the unequivocal assignment of the position and direction of the
peptide chain. There were three sections of uninterpretable electron
density corresponding to residues 193–207, 250–272 and 306–310.
Clear density corresponding to the NADP and to the ADP-glucose was
readily identified in the experimental maps. The known NCS operators
were used to generate the two complete pentamers. Subsequent
refinement was carried out using all data from 25.0–2.0 Å resolution
and a bulk-solvent correction was applied with X-PLOR [32]. The appli-
cation of overall anisotropic scaling parameters resulted in a significant
drop in both the conventional R factor and the free R factor (by about
6% each) and proved crucial in improving the quality of the electron-
density maps. The relative temperature factors between the b direction
and the a and c directions was about 20 Å2. The refinement consisted
of several rounds of simulated annealing followed by manual rebuilding
in O. Several residues were added to the starting model. Additionally a
molecule of NADP was fitted to each monomer.
The quality of the electron density for the catalytic inhibitor ADP-glucose
varied significantly between the individual subunits, in particular the
glucose tended to be disordered. Strict NCS restraints of 500 kcal/mol
were used in the initial stages of the refinement. As the model improved
the restraints were relaxed gradually as judged by the free R factor. At no
stage in the refinement did the free R factor indicate that NCS restraints
could be completely removed. NCS restraints of 100 kcal/mol were still
used for the bulk of the final model, although restraints were removed
from a few regions of the polypeptide chain. Water molecules were
added at positions with > 3σ density in the Fo–Fc maps according to
reasonable geometry criteria. The final round of positional and B-factor
refinement yielded an R factor of 21.2% and a free R factor of 26.2%.
The final model contains ten monomers of AGME each with a tightly
bound molecule of NADP and a more disordered molecule of ADP-
glucose (in some molecules the glucose moiety was too disordered to
be modeled into the electron density so only the ADP was included).
Accession numbers
The coordinates for the AGME model have been deposited with the
Protein Data Bank with accession code 1EQ2.
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